Monday, October 14, 2024 from 3:30 PM to 5:00 PM MST at Convention Center North Building / Meeting Room 131
This session will feature the finalists for the Best Poster award.
Best Poster Finalists
Sat-87 CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention in patients with high bleeding risk: evaluating the clinical impact in a real-world setting, Ashton Pearce, PharmD, MSCR, University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, North Carolina
Sat-106 Polygenic interactions with anticholinergic burden impact cognition and brain structure in psychotic disorders, Lusi Zhang, Pharm.D., MHI, University of Minnesota College of Pharmacy, Minneapolis, Minnesota
Sat -111 Granulocyte colony stimulating factor use in alemtuzumab vs anti-thymocyte globulin induction with rapid steroid withdrawal regimen in adult kidney transplant recipients, Kristen Szempruch, PharmD, BCPS, BCTXP, University of North Carolina Medical Center, Chapel Hill, North Carolina